Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 7Neoplasm Metastasis 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Pancreatic Neoplasms 3Lymphoma, T-Cell, Cutaneous 3Lymphoma 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Sezary Syndrome 2Ovarian Neoplasms 2Mycosis Fungoides 2Lymphoma, Large-Cell, Anaplastic 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Basal Cell 1Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1

Interventions

sonidegib 2HhAntag691 2Fluorouracil 2methyl 5-aminolevulinate 1folfirinox 1Taxes 1Risk Factors 1Oxaliplatin 1Lighting 1Leucovorin 1Irinotecan 1Infectious Disease Incubation Period 1Gemcitabine 1Erlotinib Hydrochloride 1BF-200 ALA 1Aminolevulinic Acid 1Albumin-Bound Paclitaxel 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Basal Cell × Leucovorin × Dermatologic × Clear all
NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
104 enrolled
DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡